Concepts (157)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Substance Abuse, Intravenous | 20 | 2022 | 123 | 6.950 |
Why?
|
| Sexual Partners | 21 | 2021 | 308 | 4.020 |
Why?
|
| HIV Infections | 27 | 2024 | 2207 | 2.820 |
Why?
|
| Pregnancy Complications | 3 | 2021 | 132 | 1.840 |
Why?
|
| Sexual Behavior | 14 | 2019 | 587 | 1.780 |
Why?
|
| Neonatal Abstinence Syndrome | 2 | 2021 | 9 | 1.480 |
Why?
|
| Risk-Taking | 14 | 2021 | 435 | 1.400 |
Why?
|
| Mexico | 21 | 2018 | 223 | 1.320 |
Why?
|
| Violence | 4 | 2022 | 126 | 1.250 |
Why?
|
| Opioid-Related Disorders | 2 | 2021 | 112 | 1.250 |
Why?
|
| Substance-Related Disorders | 7 | 2021 | 685 | 1.210 |
Why?
|
| Prenatal Care | 2 | 2018 | 74 | 1.210 |
Why?
|
| Kenya | 8 | 2022 | 51 | 1.180 |
Why?
|
| Qualitative Research | 13 | 2019 | 393 | 1.150 |
Why?
|
| Adult | 37 | 2021 | 11034 | 1.080 |
Why?
|
| Interpersonal Relations | 9 | 2018 | 198 | 0.990 |
Why?
|
| Female | 40 | 2022 | 19873 | 0.950 |
Why?
|
| Syringes | 2 | 2021 | 6 | 0.950 |
Why?
|
| Needle-Exchange Programs | 2 | 2021 | 7 | 0.940 |
Why?
|
| Heroin | 3 | 2018 | 11 | 0.920 |
Why?
|
| Unsafe Sex | 8 | 2018 | 161 | 0.910 |
Why?
|
| Health Personnel | 3 | 2021 | 200 | 0.880 |
Why?
|
| Humans | 50 | 2024 | 34853 | 0.820 |
Why?
|
| Heroin Dependence | 2 | 2018 | 23 | 0.810 |
Why?
|
| Buprenorphine | 1 | 2021 | 19 | 0.790 |
Why?
|
| Health Knowledge, Attitudes, Practice | 4 | 2017 | 790 | 0.770 |
Why?
|
| Sexually Transmitted Diseases | 7 | 2018 | 165 | 0.750 |
Why?
|
| Young Adult | 18 | 2019 | 4012 | 0.750 |
Why?
|
| Drug Users | 4 | 2022 | 42 | 0.750 |
Why?
|
| California | 8 | 2021 | 436 | 0.710 |
Why?
|
| Health Services Accessibility | 4 | 2022 | 531 | 0.710 |
Why?
|
| Commerce | 2 | 2019 | 81 | 0.690 |
Why?
|
| Postnatal Care | 1 | 2018 | 12 | 0.680 |
Why?
|
| Perinatal Care | 1 | 2018 | 15 | 0.680 |
Why?
|
| Male | 32 | 2020 | 18870 | 0.660 |
Why?
|
| Interviews as Topic | 10 | 2019 | 356 | 0.650 |
Why?
|
| Spouses | 1 | 2017 | 29 | 0.630 |
Why?
|
| Crime | 1 | 2017 | 26 | 0.610 |
Why?
|
| Methamphetamine | 5 | 2021 | 155 | 0.580 |
Why?
|
| Family Characteristics | 3 | 2017 | 102 | 0.580 |
Why?
|
| Love | 1 | 2015 | 6 | 0.540 |
Why?
|
| Decision Making | 1 | 2017 | 189 | 0.540 |
Why?
|
| Trust | 2 | 2017 | 119 | 0.520 |
Why?
|
| United States | 11 | 2021 | 3894 | 0.520 |
Why?
|
| Social Sciences | 1 | 2014 | 4 | 0.510 |
Why?
|
| Needle Sharing | 3 | 2021 | 10 | 0.470 |
Why?
|
| Anti-HIV Agents | 1 | 2017 | 394 | 0.460 |
Why?
|
| Research | 1 | 2014 | 159 | 0.450 |
Why?
|
| Harm Reduction | 2 | 2024 | 20 | 0.420 |
Why?
|
| Condoms | 6 | 2014 | 132 | 0.410 |
Why?
|
| Adaptation, Psychological | 2 | 2018 | 358 | 0.410 |
Why?
|
| Drug and Narcotic Control | 1 | 2010 | 10 | 0.390 |
Why?
|
| Anti-Infective Agents | 3 | 2018 | 62 | 0.390 |
Why?
|
| Population Surveillance | 1 | 2012 | 231 | 0.380 |
Why?
|
| Ohio | 2 | 2021 | 13 | 0.380 |
Why?
|
| Data Collection | 4 | 2016 | 188 | 0.360 |
Why?
|
| Pregnancy | 3 | 2021 | 1503 | 0.360 |
Why?
|
| Adolescent | 9 | 2021 | 5035 | 0.340 |
Why?
|
| Obesity, Morbid | 2 | 2018 | 17 | 0.330 |
Why?
|
| Bariatric Surgery | 2 | 2018 | 14 | 0.330 |
Why?
|
| Mass Screening | 1 | 2012 | 427 | 0.320 |
Why?
|
| Prevalence | 9 | 2022 | 1425 | 0.320 |
Why?
|
| Patient Acceptance of Health Care | 4 | 2018 | 375 | 0.300 |
Why?
|
| Homosexuality, Male | 3 | 2018 | 438 | 0.300 |
Why?
|
| Infant, Newborn | 2 | 2021 | 871 | 0.300 |
Why?
|
| Socioeconomic Factors | 6 | 2018 | 1003 | 0.290 |
Why?
|
| Alcoholism | 2 | 2018 | 220 | 0.270 |
Why?
|
| Amphetamine-Related Disorders | 2 | 2015 | 63 | 0.250 |
Why?
|
| Risk Factors | 9 | 2021 | 3414 | 0.240 |
Why?
|
| Pharmaceutical Preparations | 2 | 2024 | 74 | 0.230 |
Why?
|
| Social Support | 3 | 2014 | 356 | 0.220 |
Why?
|
| Feminism | 1 | 2022 | 3 | 0.220 |
Why?
|
| Middle Aged | 11 | 2019 | 9642 | 0.220 |
Why?
|
| Aggression | 1 | 2022 | 75 | 0.210 |
Why?
|
| Soft Tissue Infections | 1 | 2021 | 6 | 0.210 |
Why?
|
| Africa South of the Sahara | 3 | 2019 | 43 | 0.200 |
Why?
|
| Methadone | 1 | 2021 | 16 | 0.200 |
Why?
|
| Sex Factors | 2 | 2015 | 859 | 0.200 |
Why?
|
| Hepatitis C | 1 | 2022 | 120 | 0.190 |
Why?
|
| Negotiating | 2 | 2017 | 26 | 0.180 |
Why?
|
| Pharmaceutical Services | 1 | 2019 | 22 | 0.180 |
Why?
|
| Rectum | 1 | 2018 | 22 | 0.170 |
Why?
|
| Cross-Sectional Studies | 4 | 2015 | 2561 | 0.170 |
Why?
|
| Telemedicine | 1 | 2021 | 163 | 0.160 |
Why?
|
| Role | 1 | 2017 | 10 | 0.160 |
Why?
|
| Feasibility Studies | 2 | 2024 | 196 | 0.160 |
Why?
|
| Safe Sex | 1 | 2017 | 73 | 0.150 |
Why?
|
| Gender Identity | 1 | 2017 | 93 | 0.150 |
Why?
|
| Alcohol Drinking | 2 | 2018 | 490 | 0.150 |
Why?
|
| Reproductive Health Services | 1 | 2016 | 9 | 0.150 |
Why?
|
| Photography | 1 | 2017 | 46 | 0.150 |
Why?
|
| Postoperative Complications | 1 | 2018 | 206 | 0.150 |
Why?
|
| Behavior, Addictive | 1 | 2017 | 33 | 0.150 |
Why?
|
| Income | 1 | 2017 | 135 | 0.150 |
Why?
|
| Drug Contamination | 1 | 2016 | 4 | 0.140 |
Why?
|
| Public Health | 3 | 2020 | 348 | 0.140 |
Why?
|
| Anthropology, Cultural | 1 | 2016 | 10 | 0.140 |
Why?
|
| Vulnerable Populations | 2 | 2014 | 132 | 0.140 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2016 | 155 | 0.130 |
Why?
|
| Healthcare Disparities | 1 | 2019 | 446 | 0.130 |
Why?
|
| Attitude of Health Personnel | 1 | 2016 | 186 | 0.130 |
Why?
|
| Contact Tracing | 1 | 2014 | 17 | 0.130 |
Why?
|
| Medically Underserved Area | 1 | 2015 | 98 | 0.130 |
Why?
|
| Condoms, Female | 1 | 2014 | 1 | 0.130 |
Why?
|
| Public Policy | 1 | 2014 | 31 | 0.130 |
Why?
|
| Research Subjects | 1 | 2014 | 31 | 0.120 |
Why?
|
| Prisoners | 1 | 2015 | 83 | 0.120 |
Why?
|
| HIV Seropositivity | 1 | 2015 | 182 | 0.120 |
Why?
|
| Cocaine | 1 | 2016 | 219 | 0.120 |
Why?
|
| Truth Disclosure | 1 | 2013 | 24 | 0.110 |
Why?
|
| Risk Reduction Behavior | 1 | 2014 | 121 | 0.110 |
Why?
|
| Patient Compliance | 1 | 2014 | 202 | 0.110 |
Why?
|
| Eligibility Determination | 1 | 2012 | 6 | 0.110 |
Why?
|
| Sample Size | 1 | 2012 | 28 | 0.110 |
Why?
|
| Clinical Protocols | 1 | 2012 | 34 | 0.110 |
Why?
|
| Substance Abuse Detection | 1 | 2012 | 27 | 0.110 |
Why?
|
| Child | 2 | 2017 | 2875 | 0.100 |
Why?
|
| Diagnostic Tests, Routine | 1 | 2012 | 47 | 0.100 |
Why?
|
| Prospective Studies | 2 | 2014 | 1353 | 0.100 |
Why?
|
| Communication | 1 | 2013 | 170 | 0.100 |
Why?
|
| Attitude to Health | 1 | 2014 | 311 | 0.100 |
Why?
|
| Age Factors | 1 | 2014 | 1007 | 0.100 |
Why?
|
| Aged | 2 | 2019 | 6448 | 0.100 |
Why?
|
| Substance Abuse Treatment Centers | 1 | 2010 | 18 | 0.100 |
Why?
|
| Patient Selection | 1 | 2012 | 154 | 0.100 |
Why?
|
| Cohort Studies | 1 | 2014 | 1422 | 0.090 |
Why?
|
| Program Development | 1 | 2010 | 225 | 0.090 |
Why?
|
| Crime Victims | 2 | 2018 | 69 | 0.070 |
Why?
|
| Family Relations | 2 | 2015 | 45 | 0.060 |
Why?
|
| Hepatitis C Antibodies | 1 | 2022 | 9 | 0.050 |
Why?
|
| Seroepidemiologic Studies | 1 | 2022 | 67 | 0.050 |
Why?
|
| Hepacivirus | 1 | 2022 | 59 | 0.050 |
Why?
|
| Abscess | 1 | 2021 | 6 | 0.050 |
Why?
|
| Police | 1 | 2020 | 16 | 0.050 |
Why?
|
| Self Care | 1 | 2021 | 150 | 0.050 |
Why?
|
| Policy Making | 1 | 2019 | 27 | 0.040 |
Why?
|
| Postoperative Period | 1 | 2018 | 26 | 0.040 |
Why?
|
| Databases, Factual | 1 | 2019 | 288 | 0.040 |
Why?
|
| Health Policy | 1 | 2019 | 149 | 0.040 |
Why?
|
| Jealousy | 1 | 2015 | 2 | 0.030 |
Why?
|
| Follow-Up Studies | 1 | 2018 | 964 | 0.030 |
Why?
|
| Homicide | 1 | 2015 | 16 | 0.030 |
Why?
|
| Women | 1 | 2014 | 26 | 0.030 |
Why?
|
| Spouse Abuse | 1 | 2014 | 43 | 0.030 |
Why?
|
| Sex Offenses | 1 | 2014 | 33 | 0.030 |
Why?
|
| Vagina | 1 | 2014 | 81 | 0.030 |
Why?
|
| Prejudice | 1 | 2014 | 101 | 0.030 |
Why?
|
| Patient Satisfaction | 1 | 2014 | 141 | 0.030 |
Why?
|
| Administration, Intravaginal | 1 | 2013 | 8 | 0.030 |
Why?
|
| Counseling | 1 | 2014 | 105 | 0.030 |
Why?
|
| Evidence-Based Practice | 1 | 2013 | 41 | 0.030 |
Why?
|
| Odds Ratio | 1 | 2014 | 517 | 0.030 |
Why?
|
| Program Evaluation | 1 | 2014 | 316 | 0.030 |
Why?
|
| Incidence | 1 | 2015 | 882 | 0.030 |
Why?
|
| Longitudinal Studies | 1 | 2015 | 841 | 0.030 |
Why?
|
| Infant | 1 | 2013 | 1014 | 0.020 |
Why?
|
| Child, Preschool | 1 | 2013 | 1318 | 0.020 |
Why?
|